Is Abbott (ABT) Insider Buying Offsetting Concerns Around Nutrition and Diagnostics Earnings Pressure?
Abbott Laboratories reported fourth-quarter 2025 sales of US$11,459 million, with net income dropping to US$1,776 million and diluted EPS from continuing operations at US$1.01, compared with the prior year. The earnings shortfall in Nutrition and…


